Programme

Programme

Tuesday 17 September 2019

Manchester Lupus and Connective Tissue Diseases Day (Pre-Congress Course)

Endorsed by the British Society of Rheumatology

08:45 – 09:00 Welcome and Introductions
09:00 – 11:00

Update Session

  • UCTD-MCTD-CTD What’s in a Name or When Does Lupus begin?
  • Inflammatory Myositis, Clinical and Auto-antibody Subsets
  • Sjogren’s Syndrome – Monitoring and Assessment for Long-Term Complications
  • Systemic Lupus Erythematosus – Lessons Learned from observational cohorts
11:00 – 11:30 Morning Refreshment Break
11:30 – 13:00

Management Session

  • Prevention and Management of Digital Ulceration in Systemic Sclerosis
  • Management of Interstitial Lung Disease in Patients with CTD’s
  • Biological Therapies in SLE
13:00 – 14:00 Lunch
14:00 – 16:00

Case based discussions: Thrombosis and Haemostasis in Lupus and CTD’s

  • VTE Management
  • Stroke Management
  • Pregnancy
16:00 – 16:30 Afternoon Refreshment Break
16:30 – 19:00 Registration and Opening Ceremony for 16th International Congress of Antiphospholipid Antibodies
Welcome To Manchester

Wednesday 18 September 2019

16th International Congress on Antiphospholipid Antibodies (ICAPA 2019)

08:00 – 09:00 Task Force Session (1)
09:00 – 12:30 Plenary Session
ICAPA/International Society of Thrombosis and Haemostasis
12:30 – 13:30 Lunch and Poster Session
Task Force Session (2) Satellite Session (1)
13:30 – 17:00

Parallel Sessions

APS: Therapeutics (Preclinical and Clinical Therapeutics)

APS: Epidemiology

Parallel Sessions

APS: Beyond Classic Criteria I

APS: Beyond Classic Criteria I

17:30 – 18:30 Debate:
“DOACs have a no role in the management of APS”
Pro and Con 2 vs 2 (tbc )
Evening Speaker/Faculty Dinner

Thursday 19 September 2019

16th International Congress on Antiphospholipid Antibodies (ICAPA 2019)

08:00 – 09:00 Task Force Session (3) Task Force Session (4)
09:00 – 12:30 Plenary Session
Pregnancy and APS
12:30 – 13:30 Lunch
Task Force Session (5) Satellite Session (2)
APS Action Update
13:30 – 17:00

Parallel Sessions

APS in SLE and other autoimmune conditions
(inc SLE and autoimmunity)

APS in SLE and other autoimmune conditions
(inc renal disease and role of complement)

Parallel Sessions

APS: Practical Problems in Routine Management I

APS: Practical Problems in Routine Management II

17:30 – 18:30 Curb-Side Consults
“Panic on the Streets of Manchester!”
Discussants: (+4 Fellows to present)
Evening Congress Dinner

Friday 20 September 2019

16th International Congress on Antiphospholipid Antibodies (ICAPA 2019)

08:00 – 09:00 Task Force Session (6) APS Committee Meeting
09:00 – 12:30 Plenary Session
APS beyond 2022: how do we see the future?
Patient Education Session
12:30 – 13:30 Lunch
Satellite Session (3) EULAR/ACR Classification Criteria
Update Session
13:30 – 17:00

Parallel Sessions

Joint Patient Session (Priority Setting) I

Joint Patient Session (Priority Setting) II

Parallel Sessions

APS and Cardiovascular Risk

APS and the Central Nervous System

17:30 – 18:30 Closing Remarks

Social Programme

Tuesday 17 September 2019
Welcome Reception
Manchester Central
16:30 – 19:00

On Tuesday evening from 16:30 – 19:00 all participants are invited to join us for welcome drinks and nibbles.

 This is the official welcome for delegates to Manchester. The welcome reception is an informal evening, open to all attendees at no extra cost.

 

Thursday 19 September 2019
Delegate’s Dinner
Science and Industry Museum
19:30 – late

The social highlight, ICAPA 2019 Delegates Dinner, will take place on Thursday 19 September 2019 in the Science and Industry Museum. You will be able to dine amongst some of the world’s oldest and most fascinating exhibits from the fields of science and engineering, including the first stored-programme computer.

Register today!

A key focus of the congress will be to involve young investigators and the next generation of leaders from clinical and non-clinical disciplines. We believe that capacity building and encouraging new investigators will helps us drive this area forward over the next few years.We also have an exciting patient programme in the congress to help us better understand fully the unmet needs and plan and prioritise future research.